New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GOOG;EMC;VMW;INTC;GILD;FRX From The Last 14 Days
Check below for free stories on GOOG;EMC;VMW;INTC;GILD;FRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
April 17, 2014
08:45 EDTGOOGThe Cato Institute to hold a discussion
Subscribe for More Information
08:18 EDTGOOGGoogle capex expansion positive for Finisar, Juniper, says Janney Capital
Subscribe for More Information
08:12 EDTGOOGGoogle price target lowered to $660 from $690 at BofA/Merrill
Subscribe for More Information
07:24 EDTGOOGFutures lower as earnings disappoint
U.S. equity futures are lower following disappointing earnings reports from tech giants IBM (IBM) and Google (GOOG). Earnings will be taking center stage for the next few weeks Meanwhile, investors will continue to analyze economic data. Expected to be released today are weekly jobless claims data and the natural gas inventory report.
06:51 EDTGOOGGoogle shares still compelling, says Cantor
Subscribe for More Information
05:56 EDTGOOGGoogle price target lowered to $625 from $665 at Deutsche Bank
Deutsche Bank lowered its price target for Google shares to $625 following the company's Q1 results but it continues to view the stock as a top idea. The firm views the results as in-line and it keeps a Buy rating on Google.
05:49 EDTGOOGGoogle price target raised to $735 from $725 at Credit Suisse
Credit Suisse raised its price target for Google shares to $735 and reiterates an Outperform rating on the stock following the company's Q1 results. Credit Suisse views the results as mixed, but says the most important takeaway was the positive inflection in the CPC decline rate.
April 16, 2014
18:55 EDTGOOGOn The Fly: After Hours Movers
Subscribe for More Information
17:57 EDTGOOGYahoo seeks default search status for Apple products, Re/code says
Subscribe for More Information
16:42 EDTGOOGGoogle says Moto G showed 'strong sales momentum' in emerging markets
Comment made on company's Q1 earnings webcast.
16:40 EDTGOOGOn The Fly: Closing Wrap
Stocks on Wall Street were higher after Fed Chair Janet Yellen struck a dovish tone in comments to the Economic Club of New York, which was in step with the minutes of the last FOMC meeting released last week. The Fed also released its latest Beige Book report, which indicated that economic activity increased in most regions after the severe winter weather that gripped much of the country to start the year had let up. Corporate earnings season continues to pick up steam, with Dow members IBM (IBM) and American Express (AXP), as well as Google (GOOG), reporting after the market close. ECONOMIC EVENTS: In the U.S., housing starts in March were up 2.8% from the prior month to a rate of 946K, versus expectations for an increase of 7%. Building permits were down 2.4% to a 990K rate, versus expectations for a decline of 0.4%. Industrial production rose 0.7% in March, which was ahead of the 0.5% forecast. The Fed's Beige Book report indicated that economic activity rebounded and strengthened in most regions over the last six week. In China, data showed its economy grew 7.4% in the first quarter from a year earlier, providing relief after recent signs that growth in the world's second largest economy has been slowing. COMPANY NEWS: Bank of America (BAC) fell 26c, or 1.59%, to $16.13 after the bank reported a first quarter loss of 5c per share, largely due to $6B in legal charges. Excluding the impact of this litigation expense, which was related to a previously announced settlement with the Federal Housing Finance Agency and other legacy mortgage-related matters, the banking major reported earnings that appeared to beat estimates... Yahoo (YHOO) gained $2.14, or 6.26%, to $36.35 after its quarterly report, with investors reacting most positively to the 66% year-over-year revenue growth reported by Chinese e-commerce company Alibaba, in which Yahoo holds a 24% stake. Yahoo's quarterly profit and revenue also beat expectations and the company's CEO Marissa Mayer said during its earnings webcast that the search giant's core business has moved from declining growth to stable to modest growth. MAJOR MOVERS: Among the notable gainers was CBS Outdoor (CBSO), which jumped $1.94, or 6.69%, to $30.96 after the IRS approved a plan for the company, which was just last week spun-off from its parent CBS (CBS), to convert into a real estate investment trust, or REIT. Other companies seeking REIT status, including Equinix (EQIX), Iron Mountain (IRM) and Lamar Advertising (LAMR), also rose following CBS' announcement. Also higher was drugmaker Zogenix (ZGNX), up 48c, or 20.51%, to $2.82 after confirming that a judge prevented a ban on sales of the company's Zohydro pain medication in Massachusetts. Among the noteworthy losers were U.S.-listed shares of Credit Suisse (CS), which fell 54c, or 1.7%, to $31.22 after the Swiss bank reported net income and revenue that fell when compared to the prior year. Also lower were Agnico Eagle Mines (AEM) and Yamana Gold (AUY) after agreeing to jointly acquire Osisko Mining. Angico shares fell $2.61, or 8.56%, to $27.88, while Yamana was down 36c, or 4.3%, to $8.02. INDEXES: The Dow was up 162.29, or 1.0%, to 16,424.85, the Nasdaq was up 52.06, or 1.29%, to 4,086.23, and the S&P 500 was up 19.33, or 1.05%, to 1,862.31.
16:06 EDTGOOGGoogle down more than 5% after missing on top and bottom lines
Subscribe for More Information
16:06 EDTGOOGGoogle says expects to continue to make 'significant capital expenditures'
Reports net cash provided by operating activities in Q1 totaled $4.39B, compared to $3.63B in the prior year period. In Q1, capital expenditures were $2.35B, the majority of which was for production equipment, data-center construction, and real estate purchases. Free cash flow in Q1 was $2.05B.
16:04 EDTGOOGGoogle reports Q1 average cost-per-click down 9%
Reports paid click up 26%. Reports traffic acquisition costs increased to $3.23B vs $2.96B for the prior year period.
16:03 EDTGOOGGoogle reports Q1 sites revenue up 21% to $10.47B
Reports Q1 network revenues up 4% to 3.4B.
16:03 EDTGOOGGoogle reports Q1 EPS $6.27, consensus $6.40
Subscribe for More Information
15:17 EDTGOOGNotable companies reporting after market close
Subscribe for More Information
14:54 EDTGOOGGoogle April 550 straddle priced for 5.3% move into Q1
Subscribe for More Information
10:51 EDTINTCOptions with decreasing implied volatility: DLLR FAST INTC
Subscribe for More Information
10:00 EDTINTCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:23 EDTVMWVMware revenue, EPS should beat consensus, says Goldman
Subscribe for More Information
08:34 EDTGILDPiper Jaffray tech and biopharma analysts hold analyst/industry conference call
Technical Analyst Johnson, along with BioPharma Analysts, discuss the recent downturn in the biotech and specialty pharmaceuticals industries on an Analyst/Industry conference call to be held on April 17 at 10 am.
08:20 EDTINTCIntel results, guidance were good, says Wells Fargo
Wells Fargo says that Intel's gross margin for its March quarter beat expectations, while the company guided for sequential revenue growth for its June quarter. The firm thinks the company is making some headway in penetrating the tablet market, and keeps an Outperform rating on the shares.
07:43 EDTINTCIntel price target raised to $35 from $32 at Jefferies
Subscribe for More Information
07:40 EDTGOOGGoogle Play Q1 downloads exceeded downloads from Apple store, App Annie says
Subscribe for More Information
07:30 EDTVMWVMware, Citrix may be threatened as OpenStack momentum builds, WSJ says
OpenStack supporters say the open-source operating system can bring the ease of use and agility offered by cloud-service vendors, while using a company's own server systems, and if it continues to be adopted OpenStack could pose a threat to companies to offer data center software and services including VMware (VMW), Citrix Systems (CTXS), Amazon.com (AMZN), Microsoft (MSFT) and others, said The Wall Street Journal. Reference Link
07:07 EDTGOOG, EMCAmazon, Google, Microsoft cut prices for cloud computing products, WSJ says
Subscribe for More Information
06:52 EDTGOOGSamsung objects to Apple's patent claims in $2B court battle, Bloomberg says
Subscribe for More Information
06:50 EDTGOOGGoogle could be working on smart contact lenses, Business Insider says
Subscribe for More Information
06:08 EDTGOOGGoogle seeking third-party developers for 'modular' project, WSJ reports
Subscribe for More Information
06:06 EDTINTCIntel price target raised to $30 from $28 at Deutsche Bank
Deutsche Bank raised its price target for Intel shares to $30 citing the company's "solid" Q1 results. The firm views Intel's second half guidance as conservative and keeps a Buy rating on the stock.
05:43 EDTINTCIntel downgraded to Neutral from Buy at B. Riley
Subscribe for More Information
April 15, 2014
18:58 EDTINTCOn The Fly: After Hours Movers
Subscribe for More Information
18:48 EDTINTCIntel CFO says plans to capitalize on the Internet of Things
Subscribe for More Information
17:51 EDTINTCIntel says 'squarely on track' to ship 40M tablet SOC's in 2014
Subscribe for More Information
16:30 EDTINTCIntel CFO sees gross margins 'in low 60's' in back half of 2014
Says making investments in mobile space. Says companies are buying new PC's to replace older installed base. Intel CFO Stacy Smith is speaking on CNBC.
16:15 EDTINTCIntel reports Q1 PC Client Group revenue $7.9B, down 8% sequentially
Subscribe for More Information
16:09 EDTINTCIntel rises to new 52-week high after results, first look
Subscribe for More Information
16:07 EDTINTCIntel CEO says saw solid growth in the data center in Q1
"In the first quarter we saw solid growth in the data center, signs of improvement in the PC business, and we shipped 5 million tablet processors, making strong progress on our goal of 40 million tablets for 2014," said Intel CEO Brian Krzanich. "Additionally, we demonstrated our further commitment to grow in the enterprise with a strategic technology and business collaboration with Cloudera, we introduced our second-generation LTE platform with CAT6 and other advanced features, and we shipped our first Quark products for the Internet of Things."
16:06 EDTINTCIntel sees Q2 gross margin 63%, plus or minus a couple of percentage points
Subscribe for More Information
16:05 EDTINTCIntel sees FY14 revenue approximately flat, consensus $53.15B
Sees FY14 gross margin 61%, plus or minus a few percentage points. Sees FY14 CapEx $11B, plus or minus $500M.
16:04 EDTINTCIntel reports Q1 gross margin 59.7%
Subscribe for More Information
16:03 EDTINTCIntel sees Q2 revenue $13B, plus or minus $500M, consensus $12.96B
Subscribe for More Information
16:02 EDTINTCIntel reports Q1 EPS 38c, consensus 37c
Reports Q1 revenue $12.8B, consensus $12.81B.
15:19 EDTINTCNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Intel (INTC), consensus 37c; Yahoo (YHOO), consensus 37c; CSX (CSX), consensus 37c; Linear Technology (LLTC), consensus 48c; Wintrust Financial (WTFC), consensus 67c.
15:10 EDTINTCIntel April 26 straddle priced for 4% move into Q1
Subscribe for More Information
15:03 EDTGILDGilead treatment of chronic lymphocytic leukemia granted orphan status
The FDA granted the orphan designation on April 14, according to a post to the regulator's website. Reference Link
14:25 EDTINTCIntel April option elevated into Q1 and outlook
Intel April call option implied volatility is at 41, May is at 21, June and October is at 19; compared to its 26-week average of 21 according to Track Data, suggesting large near term price movement into the release of Q1 results today after the market close.
13:49 EDTINTCEarnings Preview: Analysts optimistic on Intel ahead of Q1 report
Subscribe for More Information
13:18 EDTGOOGDaniel Graf to join Twitter's product team
Daniel Graf, who led efforts on Google Maps (GOOG), is joining Twitter's (TWTR) product team, Graf announced in a tweet. Reference Link
12:45 EDTGOOGEarnings Preview: Google shares down 8% since last earnings report
Google (GOOG, GOOGL) is expected to report first quarter earnings after the market close on Wednesday, April 16 with a conference call scheduled for 4:30 pm ET. Google is a global technology company that focuses on Internet search, cloud computing, and advertising technologies. EXPECTATIONS: Analysts are looking for earnings per share of $6.39 on revenue of $15.52B. The consensus range is $5.83-$6.96 for EPS, and $14.94B-$16.12B for revenue, according to First Call. LAST QUARTER: Google reported Q4 EPS $12.01 against estimates of $12.26 on revenue of $16.86B against estimates of $16.75B. Google reported Q4 paid clicks up 31% and average cost-per-click decreased approximately 11%. The company also reported Q4 Sites revenue $10.55B and Q4 Network revenue $3.52B. NEWS: Google effectively split its stock with a dividend distribution of Class C shares, which began trading in early April. In the past quarter, the company reached a deal with a European Union after sending an improved commitments proposal in context of the ongoing antitrust investigation on online search and search advertising. Google also announced that it resolved the copyright litigation with Viacom (VIA, VIAB). The company announced partnerships and agreements with VMware (VMW), Cisco (CSCO), and OmniVision (OVTI) as well as acquisitions of SlickLogin, Titan Aerospace and parts of Green Throttle Games. STREET RESEARCH: Cantor said Google is being boosted by product listing ads, which are expected to increase the company's 2014 ad revenue by $1B. Atlantic Equities and Bernstein said Google's weakness provides a buying opportunity, citing strong year-over-year revenue growth at "core Google." Bernstein added predictions that Google Play, Computer and App Engine, and Apps for Enterprise and government will become multi-billion dollar businesses. Ahead of the Q1 earnings, Susquehanna said the results should beat expectations due to continued website growth, PLAs, and early benefits from Enhanced Campaigns and YouTube. PRICE ACTION: Google shares have dropped over 8% since the first day of trading following the company's Q4 report. In Tuesday midday trading ahead of Q1 report, Google shares are down a little over 2%.
08:39 EDTGOOGNetlist patent with LRDIMM claims confirmed in reexamination
Subscribe for More Information
08:20 EDTGOOGAeroVironment has limited comparability to Google acquisition, says CRT Capital
Subscribe for More Information
07:11 EDTGOOGLattice FPGAs selected by Google ATAP Group for Project Ara smartphone prototype
Subscribe for More Information
06:46 EDTGOOGGoogle price target raised to $700 from $650 at Jefferies
Jefferies raised its price target for Google shares to $700 ahead of the company's Q1 results on Wednesday and it keeps a Buy rating on the stock. The new price target reflects the sale of Motorola. Jefferies notes its survey indicates Google's traffic trends were solid in Q1.
06:38 EDTGOOGGoogle to use satellites to take photos, expand use of Internet, NY Times says
Google said that it would use Titan Aerospace's drone satellites to take photos of the Earth and connect people to the Internet, according to The New York Times. Google announced yesterday that it would buy Titan. Reference Link
06:02 EDTGOOGGoogle Glass goes on sale to U.S. residents today, USA Today reports
Beginning at 9 am ET, Google Glass will be available for U.S. residents for $1,500 plus tax, USA Today reports. This one-day sale is an expansion of the company's 2012 Glass Explorer program. Reference Link
April 14, 2014
16:00 EDTGILDOptions Update; April 14, 2014
iPath S&P 500 VIX Short-Term Futures down 32c to 44.41. Option volume leaders: AAPL C GILD TSLA LNG NQ BAC ZNGA according to Track Data.
14:06 EDTGOOGGoogle to acquire Titan Aerospace, WSJ says
Subscribe for More Information
13:32 EDTGOOGGoogle April volatility elevated at 68 into Q1 and revenue outlook
Subscribe for More Information
10:02 EDTVMWOn The Fly: Analyst Upgrade Summary
Acorda Therapeutics (ACOR) upgraded to Outperform from Market Perform at FBR Capital... Allegheny Technologies (ATI) upgraded to Neutral from Underperform at Sterne Agee... BP (BP) upgraded to Buy from Hold at Canaccord... Bloomin' Brands (BLMN) upgraded to Buy from Hold at Deutsche Bank... Boardwalk Pipeline (BWP) upgraded to Neutral from Underperform at BofA/Merrill... Boston Scientific (BSX) upgraded at BofA/Merrill... Charles Schwab (SCHW) upgraded to Buy from Neutral at UBS... Citigroup (C) upgraded to Hold from Sell at Rafferty Capital... Community Health (CYH) upgraded to Outperform from Perform at Oppenheimer... Eaton Vance (EV) upgraded to Neutral from Sell at Citigroup... Eli Lilly (LLY) upgraded to Hold from Underperform at Jefferies... F5 Networks (FFIV) upgraded to Buy from Hold at Stifel... HeartWare (HTWR) upgraded to Buy from Neutral at BTIG... Heartland Payment (HPY) upgraded to Hold from Sell at Stifel... Hyatt Hotels (H) upgraded to Outperform from Market Perform at FBR Capital... MasterCard (MA) upgraded to Outperform from Neutral at RW Baird... McDermott (MDR) upgraded to Neutral from Underweight at HSBC... Palo Alto (PANW) upgraded to Overweight at Stephens... PetroChina (PTR) upgraded to Neutral from Underperform at Credit Suisse... Seagate (STX) upgraded to Buy from Hold at Argus... Sensata (ST) upgraded to Buy from Neutral at Citigroup... Stryker (SYK) upgraded to Neutral from Reduce at SunTrust... TD Ameritrade (AMTD) upgraded to Buy from Neutral at UBS... TTM Technologies (TTMI) upgraded to Buy from Hold at Stifel... Transocean (RIG) upgraded to Hold from Sell at Deutsche Bank... VMware (VMW) upgraded to Outperform from Underperform at CLSA... Visa (V) upgraded to Outperform from Neutral at RW Baird... Yahoo (YHOO) upgraded to Buy from Neutral at SunTrust... Zimmer (ZMH) upgraded to Neutral from Reduce at SunTrust... bebe stores (BEBE) upgraded to Buy from Neutral at Janney Capital.
09:36 EDTGILDActive equity options trading on open
Subscribe for More Information
09:09 EDTGILDGilead poised to be leader in all-oral HCV treatment, says Wells Fargo
After attending the EASL conference, Wells Fargo believes that Gilead's HCV treatment has multiple advantages over the competition. The firm keeps an Outperform rating on the stock.
09:01 EDTVMW, VMWVMware upgraded to Outperform from Underperform at CLSA
Subscribe for More Information
08:15 EDTGILDBristol-Myers submits NDA for Reyataz-cobicistat combo for HIV-1
Bristol-Myers Squibb (BMY) announced the submission of a new drug application, or NDA, on April 4 to the FDA for a fixed-dose combination of atazanavir sulfate, a protease inhibitor marketed as Reyataz, and cobicistat, an investigational pharmacokinetic enhancer, or boosting agent, that can increase the level of certain HIV-1 medicines in the blood and make them more effective. Bristol-Myers Squibb is seeking approval of the fixed-dose combination tablet for use in combination with other antiretroviral agents for the treatment of HIV-1 infection. If approved, atazanavir sulfate and cobicistat could offer patients living with HIV-1 a single tablet that eliminates the need to take a boosting agent in a separate tablet. Cobicistat is being developed by Gilead Sciences (GILD). Under the terms of a previously announced agreement, Bristol-Myers Squibb and its affiliates are responsible for the formulation, manufacturing, registration, distribution and commercialization of the atazanavir sulfate and cobicistat fixed-dose combination product worldwide. Gilead retains sole rights for the manufacture, development and commercialization of cobicistat as a stand-alone product and for use in combination with other agents.
07:59 EDTGILDGilead Sovaldi should take majority share of HCV market, says Stifel
Subscribe for More Information
07:45 EDTGILDAbbVie defended at BMO Capital
Subscribe for More Information
07:06 EDTGOOG, VMWU.S. Geospatial Intelligence Foundation to hold a symposium
GEOINT 2013 Symposium, originally scheduled for October 2013, is being held in Tampa, Florida on April 14-17.
06:15 EDTVMW, VMWVMware upgraded to Outperform from Underperform at CLSA
06:11 EDTGOOG, INTCIntel works with HzO to enhance water resistance in products, DigiTimes says
Subscribe for More Information
06:04 EDTINTCIntel promoting pricing strategy for tablet CPUs in China, DigiTimes reports
Intel is aggressively promoting a pricing strategy to increase sales of its tablet-use processors in China, reports DigiTimes. According to industry sources, prices of mainstream quad-core tablet CPUs have dropped to below $5 and the number of Intel-based tablets is likely to expand in proportion. Reference Link
April 13, 2014
20:11 EDTGOOGGoogle, Palo Alto, Cvent worth looking into, Barron's says
Subscribe for More Information
April 11, 2014
12:42 EDTINTCOn The Fly: Analyst Initiation Summary
ASML (ASML) initiated with a Cautious at ISI Group... Analog Devices (ADI) initiated with a Buy at ISI Group... Applied Materials (AMAT) initiated with a Strong Buy at ISI Group... Aruba Networks (ARUN) initiated with a Buy at SunTrust... Broadcom (BRCM) initiated with a Neutral at ISI Group... CSX (CSX) initiated with an Outperform at Macquarie... Cisco (CSCO) initiated with a Buy at SunTrust... F5 Networks (FFIV) initiated with a Neutral at SunTrust... Genesee & Wyoming (GWR) initiated with a Neutral at Macquarie... Intel (INTC) initiated with a Neutral at ISI Group... Juniper (JNPR) initiated with a Buy at SunTrust... KLA-Tencor (KLAC) initiated with a Neutral at ISI Group... Lam Research (LRCX) initiated with a Strong Buy at ISI Group... Linear Technology (LLTC) initiated with a Cautious at ISI Group... Maxim Integrated (MXIM) initiated with a Neutral at ISI Group... Micron (MU) initiated with a Strong Buy at ISI Group... NVIDIA (NVDA) initiated with a Neutral at ISI Group... NXP Semiconductors (NXPI) initiated with a Strong Buy at ISI Group... Qualcomm (QCOM) initiated with a Strong Buy at ISI Group... Riverbed (RVBD) initiated with a Neutral at SunTrust... SanDisk (SNDK) initiated with a Neutral at ISI Group... Teradyne (TER) initiated with a Buy at ISI Group... Texas Instruments (TXN) initiated with a Neutral at ISI Group... Trulia (TRLA) initiated with a Neutral at Susquehanna... Union Pacific (UNP) initiated with a Neutral at Macquarie... Zillow (Z) initiated with a Positive at Susquehanna... Flamel Technologies (FLML) initiated with a Buy at Roth Capital... Parker Drilling (PKD) initiated with an Accumulate at Tudor Pickering.
12:04 EDTGILDStocks with call strike movement; AMZN GILD
Amazon.com (AMZN) May 380 call option implied volatility decreased 3% to 43, Gilead (GILD) August 77 call option implied volatility decreased 15% to 45 according to IVolatility.
09:37 EDTGILDActive equity options trading on open
Subscribe for More Information
08:58 EDTGILDGilead valuation attractive at current levels, says RBC Capital
Subscribe for More Information
07:18 EDTINTCJefferies a buyer of Intel shares ahead of Q1 results
Subscribe for More Information
06:43 EDTGOOGGoogle enhancing Android security with apps checks, Re/code says
Subscribe for More Information
06:29 EDTGOOGGoogle says 'Jelly Bean' affected by Heartbleed
Subscribe for More Information
05:57 EDTGOOGCisco, Juniper say some products affected by Heartbleed bug, WSJ reports
Both Cisco (CSCO) and Juniper (JNPR) have disclosed that some of their products are affected by the Heartbleed bug, the Wall Street Journal reports. The companies say the security flaw affects routers, switches and firewalls used by businesses. Reference Link
05:25 EDTGILDGilead announces 95% virologic suppression in HCV study
Gilead Sciences announced data from two Phase 2 studies and a compassionate access study in which a regimen containing once-daily Sovaldi 400 mg was administered for the treatment of chronic hepatitis C virus infection in patients with advanced liver disease. The first study, Study GS-US-334-0125, is an ongoing open-label Phase 2 clinical trial evaluating HCV patients with cirrhosis and portal hypertension, with or without decompensation, who were randomized 1:1 to an immediate treatment arm in which Sovaldi and ribavirin was administered for 48 weeks or to a deferred treatment arm in which this regimen was initiated after a 24-week observation period. Eighty percent of participants were treatment-experienced. Of the 22 patients who completed 24 weeks of therapy, 95% achieved virologic suppression on treatment. Additionally, patients taking Sovaldi-based therapy experienced trends in clinical and laboratory parameter improvements compared to patients in the observation arm. Sovaldi-based therapy was well tolerated in the study, and only one patient discontinued treatment due to an adverse event. The most common adverse events occurring in more than 25 percent of patients included nausea and pruritis.
April 10, 2014
16:20 EDTINTCIntel initiated with a Neutral at ISI Group
Target $26.
13:58 EDTGOOGGoogle to let any U.S. resident buy Google Glass, The Verge says
Subscribe for More Information
13:12 EDTGILDGilead volatility increases on wide price movement
Subscribe for More Information
11:44 EDTGILDStocks with call strike movement; PCLN GILD
Subscribe for More Information
11:42 EDTGILDReport claims Tamiflu, Relenza do little to prevent the spread of flu
Subscribe for More Information
10:00 EDTEMCOn The Fly: Analyst Initiation Summary
Apple (AAPL) initiated with a Buy at Deutsche Bank... Crocs (CROX) initiated with a Buy at Buckingham... Deckers Outdoor (DECK) initiated with a Buy at Buckingham... EMC (EMC) initiated with a Buy at Deutsche Bank... HP (HPQ) initiated with a Buy at Deutsche Bank... IBM (IBM) initiated with a Hold at Deutsche Bank... NeoPhotonics (NPTN) coverage resumed with a Market Perform at Raymond James... NetApp (NTAP) initiated with a Hold at Deutsche Bank... Nutrisystem (NTRI) initiated with a Buy at B. Riley... Questar (STR) initiated with an Underperform at BofA/Merrill... S&T Bancorp (STBA) initiated with an Outperform at Raymond James... STB Systems Inc (STBI) initiated with an Outperform at Raymond James... Skechers (SKX) initiated with an Underperform at Buckingham... Steven Madden (SHOO) initiated with a Buy at Buckingham... UGI Corporation (UGI) initiated with a Buy at BofA/Merrill... Web.com (WWWW) initiated with a Neutral at Buckingham... Ally Financial (ALLY) initiated with a Buy at BTIG... Visteon (VC) initiated with a Buy at Citigroup... Greatbatch (GB) initiated with a Buy at KeyBanc... Steris (STE) initiated with a Buy at KeyBanc... Cooper Companies (COO) initiated with a Hold at KeyBanc... Hill-Rom (HRC) initiated with a Hold at KeyBanc... Invacare (IVC) initiated with a Hold at KeyBanc... Teleflex (TFX) initiated with a Hold at KeyBanc... Provident Financial (PROV) initiated with a Market Perform at Keefe Bruyette... UMH Properties (UMH) initiated with a Hold at Wunderlich.
08:44 EDTEMCCLSA technology analysts hold an analyst/industry conference call
Subscribe for More Information
07:24 EDTGILDInternational Society for Heart & Lung Transplantation to hold annual meeting
Subscribe for More Information
06:52 EDTEMCEMC initiated with a Buy at Deutsche Bank
Subscribe for More Information
06:49 EDTGOOGMotorola Mobility names Osterloh COO
Subscribe for More Information
06:29 EDTGOOGAT&T in talks to bring ultrafast internet to North Carolina, WSJ reports
Subscribe for More Information
06:13 EDTINTCIntel to launch Haswell Refresh CPUs, 9-series chipsets in May, DigiTimes says
Subscribe for More Information
05:37 EDTGILDGilead announces Phase 2 results for investigational sofosbuvir-based regimens
Gilead Sciences announced data from two Phase 2 studies evaluating investigational all-oral regimens containing the nucleotide analog polymerase inhibitor sofosbuvir, or SOF, for the treatment of chronic hepatitis C virus, or HCV, infection. The first study, ELECTRON2, is an ongoing, open-label Phase 2 clinical trial evaluating a once-daily fixed-dose combination of SOF 400 mg and the NS5A inhibitor ledipasvir, or LDV, 90 mg, with and without ribavirin, or RBV, twice-daily, among HCV-infected patient populations. In this study, 100% of treatment-naïve genotype 3 patients receiving 12 weeks of LDV/SOF plus RBV and 64% of treatment-naïve genotype 3 patients receiving 12 weeks of LDV/SOF without RBV achieved a sustained virologic response 12 weeks after completing therapy. Among genotype 1-infected patients who had failed prior treatment with SOF plus RBV, 100% achieved SVR12 following 12 weeks of LDV/SOF plus RBV. Additionally, 65% of genotype 1-infected patients with decompensated or Child-Turcotte-Pugh Class B cirrhosis receiving 12 weeks of LDV/SOF without RBV achieved SVR12. LDV/SOF with and without RBV was well-tolerated, including among patients with more advanced liver disease. A second study, Study GS-US-342-0102, is an ongoing randomized Phase 2 clinical trial in which treatment-naïve, non-cirrhotic patients with genotypes 1-6 HCV infection received a 12-week course of SOF plus the pan-genotypic NS5A inhibitor GS-5816. Patients received SOF 400 mg and either GS-5816 25 mg or GS-5816 100 mg. In this study, 94.8% of patients receiving the 25 mg dose of GS-5816 and 96.1% of patients receiving the 100 mg dose achieved SVR12.
05:32 EDTGILDGilead announces results from study of Sovaldi
Subscribe for More Information
April 9, 2014
16:00 EDTGILDOptions Update; April 9, 2014
Subscribe for More Information
11:51 EDTGILDStocks with call strike movement; AAL GILD
American Airlines (ALL) August 44 call option implied volatility increased 4% to 39, Gilead (GILD) August 80 call option implied volatility decreased 2% to 34 according to IVolatility.
11:43 EDTGILDGilead defended by analysts after recent pullback
Subscribe for More Information
09:36 EDTGILDActive equity options trading on open
Subscribe for More Information
08:58 EDTGOOGGoogle Q1 results should beat expectations, says Susquehanna
Susquehanna is bullish on Google heading into Q1 results on expectations of continued website growth from mobile share gains, PLAs, early benefits from Enhanced Campaigns, and YouTube. The firm sees the company beating Street revenue estimates by 1% and earnings by 5%. Shares are Positive rated with a $700 price target
08:41 EDTGILDAttack on Gilead Sovaldi by Express Scripts 'noise,' says Maxim
After Bloomberg reported that Express Scripts (ESRX) said that it would attempt to build a coalition against the use of Gilead's (GILD) Sovaldi once a rival drug is approved, Maxim views Express Scripts' statement as "noise." The firm says that Sovaldi is not the most expensive HCV drug, and reiterates its view that Sovaldi provides "compelling" value, when including the cost of failure rates in a cost/benefit analysis. Maxim keeps a Buy rating on Gilead.
08:24 EDTGOOGGoogle, Apple have considered acquiring Square, Re/code reports
Subscribe for More Information
08:04 EDTVMWCitrix survey indicates weak demand fundamentals, says Jefferies
Subscribe for More Information
07:56 EDTGILDGilead poised for strong earnings, says RW Baird
Subscribe for More Information
07:28 EDTGOOGAmazon looking to court game developers for Fire TV, NY Post reports
Subscribe for More Information
07:23 EDTGILDEuropean Association for the Study of the Liver to hold annual meeting
Subscribe for More Information
07:00 EDTINTCBofA, Intel fire 3K workers, leaving Costa Rica shocked, Bloomberg says
Subscribe for More Information
06:20 EDTGOOGGoogle adds more photos, reviews to hotel business, WSJ says
Subscribe for More Information
06:20 EDTINTCIntel plans 1,500 job cuts in Cosa Rica, WSJ reports
Intel is planning to lay off about 1,500 employees in Costa Rica, the Wall Street Journal reports. The company will move longtime assembly and test operations in the country to three locations in Asia. The latest job cuts reduce Intel's workforce by about 1.4%. Reference Link
05:50 EDTFRXForest Labs reports FDA provided feedback on combination aclidinium, formoterol
Forest Laboratories announced that they have recently received feedback from the FDA regarding the fixed dose combination of aclidinium and formoterol. Although no new issues have arisen, further discussion is needed with the Agency in order to address questions related to CMC, or Chemistry, Manufacturing and Control, and a Type C meeting with the FDA is going to be requested, likely to be held during Q3 this year. Forest and Almirall believe that the fixed dose combination of aclidinium and formoterol can be an important therapy for U.S. COPD patients.
April 8, 2014
15:52 EDTGOOGGoogle Glass being tested by Air Force, VentureBeat says
The “BATMAN," or Battlefield Air Targeting Man-Aided (K)nowledge, team of the Air Force are beta testing Google Glass for possible use on the battlefield, reported VentureBeat. Himax Technologies (HIMX) is a supplier of components for Glass. Reference Link
13:27 EDTGOOGGoogle, Citrix to collaborate on Chromebooks
Subscribe for More Information
08:08 EDTGOOG, INTCCost to Apple, Google, Intel, of 'no-poaching' deal may be high, DealBook says
Some of the of the biggest names in tech, including Apple (AAPL), Google (GOOG), Intel (INTC)and Adobe (ADBE), are at the center of a class-action suit that seeks $9B as compensation for employees who contend the tech giants colluded to prevent their employees from being hired at rivals, reported The New York Times' DealBook. Reference Link
07:45 EDTGOOGSkybox takeover report could pressure DigitalGlobe, says Piper Jaffray
Subscribe for More Information
07:12 EDTGOOGGoogle in early talks to buy Skybox Imaging, The Information reports
Subscribe for More Information
06:48 EDTGOOGGoogle Glass catching on with companies, organizations, NY Times reports
Subscribe for More Information
06:40 EDTGOOGAmazon Fire TV takes top spot on Amazon's best sellers list, TechCrunch reports
Subscribe for More Information
06:07 EDTGOOGMicrosoft investing in 'invisible user interface' technology, WSJ reports
Subscribe for More Information
April 7, 2014
14:18 EDTGOOGGoogle licenses booking software from Expedia-backed startup, Bloomberg says
Tech giant Google (GOOG), which has been bolstering its investments in travel, is now licensing hotel-booking software from Room 77, a startup backed by Expedia (EXPE), reported Bloomberg, citing a letter sent to Room 77 shareholders that was obtained by the news service. Other online travel agencies include Priceline Group (PCLN) and Orbitz Worldwide (OWW). Reference Link
10:00 EDTINTCOn The Fly: Analyst Upgrade Summary
Agios Pharmaceuticals (AGIO) upgraded to Overweight from Neutral at JPMorgan... Alcoa (AA) upgraded to Hold from Sell at Deutsche Bank... Align Technology (ALGN) upgraded to Outperform from Market Perform at Barrington... Analog Devices (ADI) upgraded to Neutral from Sell at Goldman... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Citigroup (C) upgraded to Neutral from Underweight at HSBC... Intel (INTC) upgraded to Outperform from Sector Perform at Pacific Crest... JetBlue (JBLU) upgraded to Neutral from Sell at Goldman... Kindred Healthcare (KND) upgraded to Outperform from Sector Perform at RBC Capital... Lennox (LII) upgraded to Outperform from Market Perform at Wells Fargo... Newmont Mining (NEM) upgraded to Hold from Sell at Deutsche Bank... PBF Energy (PBF) upgraded to Buy from Neutral at Citigroup... Renasant (RNST) upgraded to Outperform from Market Perform at Raymond James... Select Medical (SEM) upgraded to Outperform from Sector Perform at RBC Capital... Ultra Petroleum (UPL) upgraded to Outperform from Market Perform at Raymond James... Under Armour (UA) upgraded to Buy from Neutral at Sterne Agee... Hercules Technology (HTGC) upgraded to Buy from Hold at Sandler ONeill... Standard Pacific (SPF) upgraded to Outperform from Market Perform at Raymond James... Yelp (YELP) upgraded to Outperform from Perform at Oppenheimer... Netflix (NFLX) upgraded to Outperform from Perform at Oppenheimer... Pandora (P) upgraded to Outperform from Neutral at Wedbush.
09:34 EDTGILDActive equity options trading on open
Subscribe for More Information
08:31 EDTGILDGilead announecs FDA priority review designation for Ledipasvir/Sofosbuvir
Gilead Sciences announced that the U.S. Food and Drug Administration has granted priority review to the company’s New Drug Application for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir 400 mg for the treatment of chronic hepatitis C genotype 1 infection in adults. Gilead filed the NDA for LDV/SOF on February 10, and the FDA has set a target action date under the Prescription Drug User Fee Act of October 10. The FDA has also assigned LDV/SOF a Breakthrough Therapy designation.
07:55 EDTGOOGGoogle looks to appeal YouTube blackout in Turkey, WSJ says
Subscribe for More Information
07:16 EDTGOOGRetailers muscle into competitive mobile payment market, Reuters says
Subscribe for More Information
06:36 EDTGOOGApple's sales force worried about iPhone outlook, Re/code reports
Apple's (AAPL) sales force has been worried about weakness in the iPhone's market share, amid strong competition from Google's (GOOG) Android operating system, a document presented in a court case showed, Re/code reported on Friday. According to the internal Apple document, the only portions of the smartphone market showing growth were large devices costing more than $300 or devices that cost less than $300, the website stated. Reference Link
05:56 EDTGOOGStocks with implied volatility movement; GOOG XLK
Subscribe for More Information
05:55 EDTINTCIntel upgraded to Outperform from Sector Perform at Pacific Crest
Pacific Crest upgraded its rating on Intel (INTC) shares to Outperform with a $31 price target citing improving corporate PC demand and expectations the company's Grantley server platform will drive spending at traditional IT customers in 2015. Shares of Intel closed Friday down 25c to $26.16.
April 6, 2014
17:48 EDTGOOGGoogle set to announce Android TV, The Verge says
Subscribe for More Information
April 4, 2014
16:38 EDTGOOGGoogle files automatic mixed securities shelf
Subscribe for More Information
16:00 EDTINTCOptions Update; April 4, 2014
iPath S&P 500 VIX Short-Term Futures up 89c to 41.88. Option volume leaders: AAPL C P NFLX LNG BAC INTC TSLA TWTR according to Track Data.
09:36 EDTGILDActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TSLA MU GNK AMZN FB GILD MA NFLX
07:43 EDTGOOGBaidu market leading search share in China rose in March, Marbridge Daily says
Subscribe for More Information
07:42 EDTGOOGGoogle pays $1.4 fine regarding StreetView worries in Italy, Reuters says
Subscribe for More Information
07:28 EDTGOOGNew America Foundation to hold a forum
The New America Foundation holds a forum, "Implementing the PCAST Spectrum Sharing Report" with President Obama's Deputy CTO for Telecom Policy, Jason Furman, VP Medin of Google and Craig Mundie of Microsoft in Washington, D.C. on April 4 at 2 pm. Webcast Link
07:25 EDTGOOGNational Press Club holds a meeting
Subscribe for More Information
06:22 EDTGOOGNest Labs halts sales of smart smoke alarms
Nest Labs announced it is stopping sales of its Nest Protect: Smoke + Carbon Monoxide alarm because of a defect that can cause owners to inadvertently turn them off. The company says "At Nest, we conduct regular, rigorous tests to ensure that our products are the highest quality. During recent laboratory testing of the Nest Protect smoke alarm, we observed a unique combination of circumstances that caused us to question whether the Nest Wave -- a feature that enables you to turn off your alarm with a wave of the hand -- could be unintentionally activated. This could delay an alarm going off if there was a real fire. We identified this problem ourselves and are not aware of any customers who have experienced this. We feel that the best and safest thing to do is to immediately disable the Nest Wave feature to resolve the issue and remove any safety concerns. While we fix Nest Wave, we have also halted sales of all new Nest Protect alarms to ensure no one buys an alarm that needs an immediate update." Google acquired Nest Labs earlier this year. Reference Link
06:01 EDTGOOGAcacia Research resolves action with Motorola Mobility
Subscribe for More Information
April 3, 2014
16:16 EDTINTCGlobalfoundries in lead to buy IBM chip plants, TSMC out of talks, WSJ says
IBM (IBM) has held talks with Globalfoundries, Intel (INTC) and Taiwan Semiconductor (TSM) regarding its semiconductor manufacturing operations, and Globalfoundries appears to be in the lead as the most likely potential buyer, according to The Wall Street Journal, citing people familiar with the matter. IBM initially asked for more than $2B and bids have come in "north of $1B," the report noted, adding that Intel is still involved, but TSMC has dropped out of the talks. Reference Link
16:00 EDTINTCOptions Update; April 3, 2014
Subscribe for More Information
15:49 EDTINTCGlobalfoundries in lead to buy IBM chip plants, TSMC out of talks, DJ says
IBM (IBM) also held talks with Intel (INTC), according to Dow Jones, citing sources.
15:10 EDTGOOGVIX methodology for Google decreases 9.2% after 2-1 stock split
VIX methodology for Google (VXGOG) is recently down 9.2% to 28.56 after 2-1 stock split
12:20 EDTGOOGGoogle considers wireless service in Fiber markets, The Information says
Subscribe for More Information
10:01 EDTINTCIntel climbs following upbeat note from analyst
Subscribe for More Information
10:00 EDTINTCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:37 EDTGILDActive equity options trading on open
Subscribe for More Information
08:54 EDTGOOGGoogle Class C shares begin trading today
Google (GOOG) is effectively splitting its stock via a dividend distribution of new "Class C" shares, which begin trading today. The price of existing Google A shares, which hold one vote each, is expected to fall by half today as the C shares begin trading. WHAT'S NOTABLE: In January, Google announced that its board approved a dividend of Class C shares to be distributed on April 2 to holders of record as of March 27. The new Class C shares will trade under the ticker "GOOG" and the company's existing Class A shares will trade under a new ticker, "GOOGL." The company has previously said that its Q1 GAAP EPS will be half of what it would otherwise report because its net earnings are divided by twice as many shares. The company also said that its non-GAAP EPS will be similarly affected by the Class C dividend issuance, but will also be impacted by the expected sale of Motorola Mobile to Lenovo (LNVGY). This sale triggers "discontinued operations" accounting treatment, Google noted. Both Google Class A and Class C will be included in the S&P 500 and S&P 100 and there will not be a switch from Class A to Class C. Class A shares will subsequently be removed from Nasdaq indexes when the exchange operator rebalances them on June 23. By introducing non-voting C shares, Google's Sergey Brin and Larry Page will be able to issue stock to compensate workers or make acquisitions without diluting their voting stake, Bloomberg has noted.
07:50 EDTGOOGNew Google shares land in market, Bloomberg says
Subscribe for More Information
06:29 EDTGOOGTaiwan makers: Chromebook shipments in 2014 to reach 4M-5M units, DigiTimes says
Subscribe for More Information
06:24 EDTGOOGGoogle could ship up to 11M Chromebooks worldwide by 2019, DigiTimes says
ABI Research believes Google could ship an estimated 11M Chromebooks in 2019 after shipping nearly 2.1M in 2013, reports DigiTimes. Research Analyst Stephanie Van Vactor said the device is a disruptive force to the portable PC market after finding the ASP to be $338. Reference Link
06:10 EDTGOOGGoogle's LeBeau hired by Facebook, TechCrunch reprots
Google (GOOG) product designer Mike LeBeau has been hired by Facebook (FB), TechCrunch reports. LeBeau had a hand in developing several voice-related technologies, including iPhone Voice Search, while working as a staff software engineer and product designer at Google, and was an early member of the Android team. LeBeau will become a product manager at Facebook. Reference Link
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use